Human Placenta: a Cure for Football Injuries?
London, United Kingdom, December 03, 2009 --(PR.com)-- Journal of Wound Care (JWC) has published a paper on the use of human aqueous placental extract to treat wounds (“Human aqueous placental extract as a wound healer” Vol. 18, Iss. 11, 06 Nov 2009, pp 462 – 46).
This paper is particularly relevant in light of the media attention surrounding the treatment applied to the injuries of Israeli international footballer Yossi Benayoun and others using placental extract administered by a Serbian physiotherapist.
The real controversy should concern whether the extract used to treat the footballers was human or equine. Contrary to various media reports, in fact, the use of human aqueous placental extract to promote wound healing is well established.
JWC’s paper written by P.D. Chakraborty, D. De, S. Bandyopadhyay and D. Bhattacharyya focuses on the biochemical components of the extract and their chemical efficacy. For example, a dressing containing human placental extract was found to be effective on chronic varicose ulcers.
The healing properties of human placental extract are used in the treatment of various ailments and skin conditions, including chronic wounds, pressure ulcers and burns. It is the only type of placental extract which promotes wound healing, and is widely used in Japan, Korea, Germany, Switzerland and New Zealand for tissue regeneration.
JWC’s paper discusses the wound healing properties of the extract. These include the areas of cell adhesion, antibacterial action, regulation of protease activity, anti-inflammatory properties and collagen syntheses. However, the paper acknowledges that the extract’s biochemical composition and the molecular mechanisms of action involved in the healing process are still largely unknown.
The benefits of using the extract in wound-healing, and its use as a rich source of growth factors, is summarized in the paper, but the importance of further study is highlighted. In particular, there is a need to characterize the active components present in different placenta preparations and to correlate them with their therapeutic action.
For additional information on the paper published by Journal of Wound Care (or for a copy), contact Anthony Kerr (Publisher), anthony.kerr@markallengroup.com or visit www.journalofwoundcare.com.
About the Journal of Wound Care (JWC) www.journalofwoundcare.com
JWC is the definitive wound-care journal and the leading source of tissue viability research and clinical information. Launched in 1992, it is designed to meet the needs of the multidisciplinary team. The journal is essential reading for all wound-care specialists - nurses, doctors and researchers -- who are keen to keep up-to-date with all developments in wound management and tissue viability, but also appeals to generalists wishing to enhance their practice. JWC is internationally renowned for its cutting edge and state-of-the-art research and practice articles. The journal also covers management, education and novel therapies. Articles are rigorously peer- reviewed by a panel of international experts.
###
This paper is particularly relevant in light of the media attention surrounding the treatment applied to the injuries of Israeli international footballer Yossi Benayoun and others using placental extract administered by a Serbian physiotherapist.
The real controversy should concern whether the extract used to treat the footballers was human or equine. Contrary to various media reports, in fact, the use of human aqueous placental extract to promote wound healing is well established.
JWC’s paper written by P.D. Chakraborty, D. De, S. Bandyopadhyay and D. Bhattacharyya focuses on the biochemical components of the extract and their chemical efficacy. For example, a dressing containing human placental extract was found to be effective on chronic varicose ulcers.
The healing properties of human placental extract are used in the treatment of various ailments and skin conditions, including chronic wounds, pressure ulcers and burns. It is the only type of placental extract which promotes wound healing, and is widely used in Japan, Korea, Germany, Switzerland and New Zealand for tissue regeneration.
JWC’s paper discusses the wound healing properties of the extract. These include the areas of cell adhesion, antibacterial action, regulation of protease activity, anti-inflammatory properties and collagen syntheses. However, the paper acknowledges that the extract’s biochemical composition and the molecular mechanisms of action involved in the healing process are still largely unknown.
The benefits of using the extract in wound-healing, and its use as a rich source of growth factors, is summarized in the paper, but the importance of further study is highlighted. In particular, there is a need to characterize the active components present in different placenta preparations and to correlate them with their therapeutic action.
For additional information on the paper published by Journal of Wound Care (or for a copy), contact Anthony Kerr (Publisher), anthony.kerr@markallengroup.com or visit www.journalofwoundcare.com.
About the Journal of Wound Care (JWC) www.journalofwoundcare.com
JWC is the definitive wound-care journal and the leading source of tissue viability research and clinical information. Launched in 1992, it is designed to meet the needs of the multidisciplinary team. The journal is essential reading for all wound-care specialists - nurses, doctors and researchers -- who are keen to keep up-to-date with all developments in wound management and tissue viability, but also appeals to generalists wishing to enhance their practice. JWC is internationally renowned for its cutting edge and state-of-the-art research and practice articles. The journal also covers management, education and novel therapies. Articles are rigorously peer- reviewed by a panel of international experts.
###
Contact
Journal of Wound Care
Anthony Kerr
+44 (0)20 7738 5454
www.journalofwoundcare.com
Anthony Kerr
+44 (0)20 7738 5454
www.journalofwoundcare.com
Contact
Categories